Efficacy and Safety of FMX103 (1.5% Minocycline Foam) in the Treatment of Moderate to Severe Papulopustular Rosacea: Results from two Phase 3 Randomized, Multicenter, Double Blind, Vehicle Controlled Studies

Main Article Content

Linda Stein Gold
James Q Del Rosso
Neal D Bhatia
et al.



Abstract not available.


Disclosures: Study sponsored by Foamix Pharmaceuticals.

Most read articles by the same author(s)

1 2 3 4 5 > >>